Kiora Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
KPRX
CUSIP
49721T101
All holders as of
Q2 2022
Type
Equity
Class
COMMON STOCK
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 49721T101 since 12/18/2024, newest first.

Filer % of Class Filed
Rosalind Advisors, Inc. 13G/A Amendment 3
9.9% 2/11/2026
Event 12/31/2025
Rosalind Advisors, Inc. 13G/A Amendment 2
9.9% 8/13/2025
Event 6/30/2025
Rosalind Advisors, Inc. 13G/A Amendment 1
9.9% 2/10/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2022 Q2 15 836 k $391 k
2022 Q1 17 831 k $517 k
2021 Q4 14 805 k $1.22 M